Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;38(3):379-93.
doi: 10.1016/j.psc.2015.05.009.

Development of New Psychopharmacological Agents for Depression and Anxiety

Alan F Schatzberg  1
Affiliations
Review

Development of New Psychopharmacological Agents for Depression and Anxiety

Alan F Schatzberg. Psychiatr Clin North Am. 2015 Sep.

Abstract

Antidepressant and anxiolytic drug development has largely stalled. This article reviews novel current programs for developing depressants and anxiolytics. Biological bases are discussed for these, as are recent results. Problems encountered are reviewed. Recently announced failed programs for other antidepressants are then discussed with an eye toward uncovering possible common elements that may explain their failures. Lastly, possible solutions for improving the likelihood of the success of antidepressant/anxiolytic agents are discussed.

Keywords: Antidepressants; Anxiolytics; Glucocorticoid antagonists; Glutamatergic agents; Ketamine; Mu-opioid agents; NMDA antagonists; Obotulinum toxin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms